Comparison of cryoprecipitate with fibrinogen concentrate for acquired hypofibrinogenaemia

被引：25

作者：

Theodoulou, A. ^{[1
]}

Berryman, J. ^{[1
]}

Nathwani, A. ^{[1
,2
]}

Scully, M. ^{[1
]}

机构：

[1] UCLH, Dept Pathol, London, England

[2] UCL, Dept Haematol, London, England

来源：

TRANSFUSION AND APHERESIS SCIENCE | 2012年 / 46卷 / 02期

关键词：

Cryoprecipitate; Fibrinogen concentrate; Acquired hypofibrinogenaemia; PLASMA; TOLERABILITY; DEFICIENCY; GUIDELINES; MANAGEMENT; EFFICACY;

D O I：

10.1016/j.transci.2011.11.005

中图分类号：

R5 [内科学];

学科分类号：

1002 ; 100201 ;

摘要：

Background: The benefits of fibrinogen concentrate in hypofibrinogenaemia have been established in congenital and has been used in acquired disorders. Most European countries have already changed their practice, using fibrinogen concentrate. Methods: We compared the use of fibrinogen concentrate in acquired hypofibrinogenaemia to cryoprecipitate, which continues to be the standard of care in the UK. We undertook a retrospective analysis of fibrinogen increment in patients treated for acquired hypofibrinogenaemia. Results: Sixty four transfusion episodes receiving cryoprecipitate and 36 episodes receiving fibrinogen concentrate were compared. The median increment following 10 donor pools (two bags) of cryoprecipitate was 0.26 g/l, compared to 0.44 g/l following 2 g of fibrinogen concentrate. Conclusion: With its superior safety profile from infectious diseases, this provides further evidence to support the use of fibrinogen concentrate. (C) 2011 Elsevier Ltd. All rights reserved.

引用

页码：159 / 162

页数：4

共 50 条

[1] MANAGEMENT OF ACQUIRED HYPOFIBRINOGENAEMIA SECONDARY TO MAJOR OBSTETRIC HAEMORRHAGE: FIBRINOGEN CONCENTRATE VERSUS CRYOPRECIPITATE
Ahmed, S.
Johnson, S.
Varadkar, S.
Fleming, J.
Fanning, R.
Flynn, C.
Byrne, B.
IRISH JOURNAL OF MEDICAL SCIENCE, 2011, 180 : 141 - 142
[2] THE EFFICACY AND SAFETY OF CRYOPRECIPITATE FOR FIBRINOGEN REPLACEMENT IN ACUTE AND CHRONIC ACQUIRED HYPOFIBRINOGENAEMIA
Winthrop, J.
Sweeney, M.
Balendran, G.
Hadjinicolaou, A.
Idris, S.
HAEMATOLOGICA, 2012, 97 : 162 - 163
[3] Fibrinogen concentrate to treat bleeding patients with acquired hypofibrinogenaemia
Hewamana, S
Collins, PW
BRITISH JOURNAL OF HAEMATOLOGY, 2006, 133 : 87 - 87
[4] The efficacy and safety of cryoprecipitate in the treatment of acquired hypofibrinogenaemia
Idris, Saad F.
Hadjinicolaou, Andreas V.
Sweeney, Mark
Winthrop, Craig
Balendran, Ghaya
Besser, Martin
BRITISH JOURNAL OF HAEMATOLOGY, 2014, 166 (03) : 458 - 461
[5] THE FIBRES STUDY: A PHASE 3, NON-INFERIORITY, RANDOMISED COMPARISON OF A NEW FIBRINOGEN CONCENTRATE VS. CRYOPRECIPITATE FOR TREATING ACQUIRED HYPOFIBRINOGENAEMIA IN BLEEDING CARDIAC SURGICAL PATIENTS
Karkouti, Keyvan
AMERICAN JOURNAL OF HEMATOLOGY, 2018, 93 (09) : E31 - E31
[6] Protocol for a phase III, non-inferiority, randomised comparison of a new fibrinogen concentrate versus cryoprecipitate for treating acquired hypofibrinogenaemia in bleeding cardiac surgical patients: the FIBRES trial
Karkouti, Keyvan
Callum, Jeannie
Rao, Vivek
Heddle, Nancy
Farkouh, Michael E.
Crowther, Mark A.
Scales, Damon C.
BMJ OPEN, 2018, 8 (04):
[7] Cryoprecipitate AHF versus Fibrinogen Concentrate for Fibrinogen Replacement in Acquired Bleeding: A Cost-Minimization Analysis
Okerberg, C. K.
Williams, L., III
Kilgore, M. L.
Marques, M. B.
Kim, C. H.
Schwartz, J.
Pham, H. P.
TRANSFUSION, 2015, 55 : 209A - 209A
[8] Fibrinogen Concentrate Vs. Cryoprecipitate for Acquired Hypofibrinogenemia in Cardiac Surgery - the FIBRES Study
Carroll, Jo
Karkouti, Keyvan
BLOOD, 2018, 132
[9] National audit of the use of fibrinogen concentrate to correct hypofibrinogenaemia
Gollop, N. D.
Chilcott, J.
Benton, A.
Rayment, R.
Jones, J.
Collins, P. W.
TRANSFUSION MEDICINE, 2012, 22 (05) : 350 - 355
[10] Which is the preferred blood product for fibrinogen replacement in the bleeding patient with acquired hypofibrinogenemia-cryoprecipitate or fibrinogen concentrate?
Cushing, Melissa M.
Haas, Thorsten
Karkouti, Keyvan
Callum, Jeannie
TRANSFUSION, 2020, 60 : S17 - S23

← 1 2 3 4 5 →